Skip to main

Acasti Pharma

ACST is nowGRCE
ACST logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More
Go to the new stock page

Frequently Asked Questions (FAQ)

As of Jul 25, 2025, the market cap for ACST stock is $42.6M

The current P/E ratio for ACST stock is -3.61

The 52-week high for ACST stock is $4.97. The current ACST stock price $undefined is 100.00% below its 52-week high

The 52-week low for ACST stock is $1.75. The current ACST stock price $undefined has increased 100.00% from its 52-week low

No, the ACST stock does not pay dividends to its shareholders

The target price for ACST stock is $5.18 based on the average of what a group of analyst think ACST stock could be worth at a future date. This is not a prediction by Public.com

How to buy ACST stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ACST stock

    Navigate to the Explore page. Then, type ACST into the search bar. When you see ACST stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ACST stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Acasti Pharma Stock Earnings

The value each ACST share was expected to gain vs. the value that each ACST share actually gained.

Acasti Pharma (ACST) reported Q1 2025 earnings per share (EPS) of -$0.24, beating estimates of -$0.25 by 4.00%. In the same quarter last year, Acasti Pharma's earnings per share (EPS) was -$0.54. Acasti Pharma is expected to release next earnings on 08/09/2024, with an earnings per share (EPS) estimate of $0.

Buy Acasti Pharma (ACST) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.